FDA Approval Summary: Pembrolizumab plus Lenvatinib for Endometrial Carcinoma, a Collaborative International Review under Project Orbis
about
FDA Approval Summary: Pembrolizumab plus Lenvatinib for Endometrial Carcinoma, a Collaborative International Review under Project Orbis
description
scientific article published on 15 April 2020
@en
name
FDA Approval Summary: Pembroli ...... nal Review under Project Orbis
@en
type
label
FDA Approval Summary: Pembroli ...... nal Review under Project Orbis
@en
prefLabel
FDA Approval Summary: Pembroli ...... nal Review under Project Orbis
@en
P2093
P50
P1476
FDA Approval Summary: Pembroli ...... nal Review under Project Orbis
@en
P2093
Dianne Spillman
Julia A Beaver
Lijun Zhang
Michael Coory
Rajeshwari Sridhara
Richard Pazdur
Sanjeeve Balasubramaniam
Shaily Arora
P356
10.1158/1078-0432.CCR-19-3979
P577
2020-04-15T00:00:00Z